Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,210 | 187 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $510.13 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $387.28 | 30 | $0 (2024) |
| Amgen Inc. | $336.44 | 42 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $277.73 | 9 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $249.94 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $248.84 | 15 | $0 (2024) |
| Amarin Pharma Inc. | $173.54 | 14 | $0 (2022) |
| Merck Sharp & Dohme LLC | $152.99 | 6 | $0 (2023) |
| Esperion Therapeutics, Inc. | $152.56 | 11 | $0 (2023) |
| Boston Scientific Corporation | $142.38 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,358 | 60 | Novo Nordisk Inc ($372.64) |
| 2023 | $763.22 | 38 | Novo Nordisk Inc ($137.49) |
| 2022 | $734.02 | 52 | Amgen Inc. ($138.32) |
| 2021 | $354.82 | 37 | Amgen Inc. ($154.53) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $29.58 | General |
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.26 | General |
| 11/15/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.94 | General |
| 11/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $119.92 | General |
| 11/06/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.12 | General |
| 11/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $35.35 | General |
| Category: LIVER DISEASE | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Vascular | ||||||
| 09/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| Category: Cardiology | ||||||
| 08/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.12 | General |
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/06/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.55 | General |
| 07/31/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 293 | 319 | $65,147 | $15,482 |
| 2022 | 4 | 322 | 355 | $64,881 | $15,941 |
| 2021 | 4 | 320 | 353 | $56,931 | $13,843 |
| 2020 | 7 | 419 | 443 | $74,016 | $13,458 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 174 | $43,560 | $11,874 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,645 | $1,451 | 21.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 78 | 79 | $11,850 | $1,026 | 8.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,242 | $697.08 | 31.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 34 | 34 | $850.00 | $434.08 | 51.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 116 | $26,680 | $8,439 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 75 | 76 | $17,480 | $4,704 | 26.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 120 | 121 | $18,150 | $1,686 | 9.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $1,846 | $740.62 | 40.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 29 | 29 | $725.00 | $371.61 | 51.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 107 | $24,610 | $7,935 | 32.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 48 | 48 | $6,816 | $2,049 | 30.1% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 122 | 130 | $19,500 | $1,850 | 9.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 21 | $4,830 | $1,379 | 28.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 46 | 47 | $1,175 | $629.33 | 53.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 80 | 96 | $22,080 | $6,497 | 29.4% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 106 | 108 | $16,200 | $1,442 | 8.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $4,725 | $1,387 | 29.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 34 | 34 | $4,828 | $1,007 | 20.9% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 106 | 108 | $18,900 | $962.18 | 5.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 15 | 15 | $3,450 | $789.90 | 22.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 17 | $2,414 | $732.73 | 30.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 35 | 37 | $925.00 | $477.45 | 51.6% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 11 | 13 | $494.00 | $163.75 | 33.1% |
About Suzanna Carlton, FNP
Suzanna Carlton, FNP is a Family healthcare provider based in Shelbyville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2016. The National Provider Identifier (NPI) number assigned to this provider is 1336695584.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Suzanna Carlton, FNP has received a total of $3,210 in payments from pharmaceutical and medical device companies, with $1,358 received in 2024. These payments were reported across 187 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,210).
As a Medicare-enrolled provider, Carlton has provided services to 1,354 Medicare beneficiaries, totaling 1,470 services with total Medicare billing of $58,725. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Shelbyville, IN
- Active Since 08/28/2016
- Last Updated 08/13/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336695584
Products in Payments
- Repatha (Biological) $306.86
- JARDIANCE (Drug) $253.53
- LEQVIO (Drug) $214.96
- Vascepa (Drug) $173.54
- ENTRESTO (Drug) $172.32
- FARXIGA (Drug) $160.76
- VERQUVO (Drug) $152.99
- NEXLETOL (Drug) $152.56
- ELIQUIS (Drug) $149.69
- WATCHMAN Access System (Device) $142.38
- Inpefa (Drug) $133.27
- XARELTO (Drug) $127.46
- Ozempic (Drug) $88.95
- Optimizer (Device) $55.26
- BRILINTA (Drug) $53.37
- MITRACLIP (Device) $43.82
- RESMETIROM (Drug) $35.35
- Veltassa (Drug) $25.75
- Assure WCD (Device) $24.87
- Kerendia (Drug) $21.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Shelbyville
Nicole Bowman, N.p, N.P
Family — Payments: $7,855
Melanie Dowell, Fnp, FNP
Family — Payments: $5,128
Dr. Kenda Harrison, Np, NP
Family — Payments: $4,108
Kathryn Neisler, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $4,073
Mrs. Kristin Mcbay, Np-C, NP-C
Family — Payments: $3,482
Arise Uwizeyimana
Family — Payments: $3,423